Ha, Dat P.
Shin, Woo-Jin
Liu, Ze
Doche, Michael E.
Lau, Roy
Leli, Nektaria Maria
Conn, Crystal S.
Russo, Mariangela
Lorenzato, Annalisa
Koumenis, Constantinos
Yu, Min
Mumenthaler, Shannon M.
Lee, Amy S. http://orcid.org/0000-0002-0378-5443
Funding for this research was provided by:
National Institutes of Health (R01 CA027607, R01 CA238029, R01 CA238029, R01 CA238029)
Italian Association for Cancer Research (MFAG 2021-ID 26439)
Article History
Received: 16 April 2024
Accepted: 27 August 2024
First Online: 6 September 2024
Declarations
:
: All animal experiments were performed in accordance with protocols and guidelines approved by the Institutional Animal Care and Use Committee at the University of Southern California (IACUC Protocol Number: 21091).
: Not applicable.
: A.S.L. is a scientific advisory board member of BiPER Therapeutics. M.Y. is the founder and president of CanTraCer Biosciences Inc. The other co-authors declare no competing interests.